Biopharmaceutical company focused on developing/commercializing innovative therapies for people with rare (orphan) neurological diseases treatable by PKG signaling modification:
Hemiplegic Migraine
Neural Trauma (TBI, Spinal shock)
Ischemic, Epileptic and other Neurological Conditions.